1 completed, 1 recruiting. 1 Early Phase 1, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Completed 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow Comanche Biopharma: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate the Safety, Pharmacodynamic and Pharmacokinetic Characteristics of CBP-4888 in Hospitalized Participants With Preterm Preeclampsia and Their Children up to 24 Months CBP-4888 - sFlt1 Mediated Preterm Preeclampsia, Preeclampsia | Phase 1 | Recruiting | Comanche Biopharma | 60 | 2025-02-26 | 2026-05-18 |
| Study of CBP-4888 in Healthy, Non-Pregnant Female Subjects CBP-4888, Placebo - Healthy Volunteer Study | Early Phase 1 | Completed | Comanche Biopharma | 45 | 2023-05-22 | 2025-09-26 |
Pre-Eclampsia (1) · Toxemia (1)
Australia (1) · United States (1)